Cost-effectiveness evaluation of the use of PCSK9 inhibitors Fernando Civeira; Juan Pedro-Botet;

Treatment of hypertriglyceridaemia with icosapent ethyl in patients with high/very high cardiovascular risk. Consensus document of the Sociedad Española de Cardiología [Spanish Society of Cardiology] and the Sociedad Española de Diabetes [Spanish Diabetes Society] Juan Pedro-Botet; Vivencio Barrios; Víctor Sánchez-Margalet; Juan Tamargo; Francisco Arrieta; José Mª Gámez; José Antonio Gimeno-Orna; Carlos Escobar; Juan José Gómez-Doblas; Antonio Pérez;

Executive summary: Updates to the dietary treatment of prediabetes and type 2 diabetes mellitus Vicente Pascual Fuster; Antonio Pérez Pérez; Juana Carretero Gómez; Assumpta Caixàs Pedragós; Ricardo Gómez-Huelgas; Pablo Pérez-Martínez;